Kuroiwa Ryota, Tateishi Yoshihisa, Oshima Taku, Inagaki Takeshi, Furukawa Seiichiro, Takemura Ryo, Kawasaki Yohei, Murata Astushi
Division of Rehabilitation Medicine, Chiba University Hospital, Chiba, Japan.
Department of Emergency and Critical Care Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Indian J Crit Care Med. 2021 Jan;25(1):62-66. doi: 10.5005/jp-journals-10071-23508.
Ventilator-associated pneumonia (VAP) is the most common intensive care unit (ICU)-acquired infection. The current study aimed to assess the efficacy of mechanical insufflation-exsufflation (MI-E) in preventing VAP in critically ill patients.
This retrospective cohort study was conducted at the ICU of Chiba University Hospital between January 2014 and September 2017. The inclusion criteria were patients who required invasive mechanical ventilation ≥48 hours and those who underwent rehabilitation, including chest physical therapy (CPT). In 2015, the study institution started the use of MI-E in patients with impaired cough reflex. From January to December 2014, patients undergoing CPT were classified under the historical control group, and those who received treatment using MI-E from January 2015 to September 2017 were included in the intervention group. The patients received treatment using MI-E via the endotracheal or tracheostomy tube, with insufflation-exsufflation pressure of 15-40 cm HO. The treatment frequency was one to three sessions daily, and a physical therapist who is experienced in using MI-E facilitated the treatment.
From January 2015 to September 2017, 11 patients received treatment using MI-E. Of the 169 patients screened in 2014, 19 underwent CPT. The incidence of VAP was significantly different between the CPT and MI-E groups (84.2% [16/19] vs 26.4% [3/11], = 0.011). After adjusting for covariates, a multivariate logistic regression analysis was performed, and results showed that the covariates were not associated with the incidence of VAP.
This retrospective cohort study suggests that the use of MI-E in critically ill patients is independently associated with a reduced incidence of VAP.
Assessing the efficacy of MI-E to prevent VAP.
Kuroiwa R, Tateishi Y, Oshima T, Inagaki T, Furukawa S, Takemura R, Mechanical Insufflation-exsufflation for the Prevention of Ventilator-associated Pneumonia in Intensive Care Units: A Retrospective Cohort Study. Indian J Crit Care Med 2021;25(1):62-66.
呼吸机相关性肺炎(VAP)是重症监护病房(ICU)获得性感染中最常见的类型。本研究旨在评估机械通气辅助咳痰(MI-E)预防重症患者发生VAP的疗效。
本回顾性队列研究于2014年1月至2017年9月在千叶大学医院ICU进行。纳入标准为需要有创机械通气≥48小时且接受康复治疗(包括胸部物理治疗[CPT])的患者。2015年,研究机构开始对咳嗽反射受损的患者使用MI-E。2014年1月至12月,接受CPT的患者被归类为历史对照组,2015年1月至2017年9月接受MI-E治疗的患者被纳入干预组。患者通过气管内或气管造口管接受MI-E治疗,通气辅助咳痰压力为15 - 40 cm H₂O。治疗频率为每天1至3次,由一名有使用MI-E经验的物理治疗师协助进行治疗。
2015年1月至2017年9月,11例患者接受了MI-E治疗。2014年筛选的169例患者中,19例接受了CPT。CPT组和MI-E组的VAP发生率有显著差异(84.2%[16/19]对26.4%[3/11],P = 0.011)。在对协变量进行调整后,进行了多因素逻辑回归分析,结果显示协变量与VAP发生率无关。
这项回顾性队列研究表明,在重症患者中使用MI-E与VAP发生率降低独立相关。
评估MI-E预防VAP的疗效。
Kuroiwa R, Tateishi Y, Oshima T, Inagaki T, Furukawa S, Takemura R, 机械通气辅助咳痰预防重症监护病房呼吸机相关性肺炎:一项回顾性队列研究。《印度重症医学杂志》2021;25(1):62 - 66。